Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

IMPORTANCE: Coronavirus disease 2019 (COVID-19) continues to spread rapidly worldwide. Neutralizing antibodies are a potential treatment for COVID-19. OBJECTIVE: To determine the effect of bamlanivimab monotherapy and combination therapy with bamlanivimab and etesevimab on severe acute respiratory s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA
Главные авторы: Gottlieb, Robert L., Nirula, Ajay, Chen, Peter, Boscia, Joseph, Heller, Barry, Morris, Jason, Huhn, Gregory, Cardona, Jose, Mocherla, Bharat, Stosor, Valentina, Shawa, Imad, Kumar, Princy, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Durante, Michael, Oakley, Gerard, Schade, Andrew E., Holzer, Timothy R., Ebert, Philip J., Higgs, Richard E., Kallewaard, Nicole L., Sabo, Janelle, Patel, Dipak R., Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M.
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2021
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821080/
https://ncbi.nlm.nih.gov/pubmed/33475701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.0202
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы